• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Insulet Corp (NQ: PODD )

    237.44 +1.83 (+0.78%)
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 4, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 538,216
    Open 236.02
    Bid (Size) 231.85 (1)
    Ask (Size) 243.00 (1)
    Prev. Close 235.61
    Today's Range 235.81 - 240.78
    52wk Range 151.56 - 243.98
    Shares Outstanding 68,873,869
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Why NASDAQ:PODD qualifies as a high growth stock.
    Is INSULET CORP (NASDAQ:PODD) suited for high growth investing? 
    Via Chartmill
    Insulet Announces Array of Activities to Support National Diabetes Awareness Month and World Diabetes Day in November
    From Insulet Corporation 
    Via Business Wire

    Performance

    YTD
    +13.55%
    +13.55%
    1 Month
    +4.24%
    +4.24%
    3 Month
    +24.59%
    +24.59%
    6 Month
    +34.60%
    +34.60%
    1 Year
    +49.41%
    +49.41%

    More News

    Read More
    Omnipod® 5 App for iPhone® Now Fully Available in the United States
    From Insulet Corporation
    Via Business Wire
    (PODD) - Analyzing Insulet's Short Interest
    Via Benzinga
    Here's How Much $1000 Invested In Insulet 10 Years Ago Would Be Worth Today
    Via Benzinga
    Is NASDAQ:PODD on the Verge of a Major Breakout as a Strong Growth Stock?
    Via Chartmill
    If You Invested $100 In This Stock 10 Years Ago, You Would Have $600 Today
    Via Benzinga
    Solventum Stock Earns 81 RS Rating
    Via Investor's Business Daily
    Analyst Ratings For Insulet
    Via Benzinga
    Is NASDAQ:PODD a Fit for high Growth Investing Strategies?
    Via Chartmill
    Exploring the Growth Potential of NASDAQ:PODD as It Nears a Breakout.
    Via Chartmill
    Insulet to Announce Third Quarter 2024 Financial Results on November 7, 2024
    From Insulet Corporation
    Via Business Wire
    Here's How Much $100 Invested In Insulet 15 Years Ago Would Be Worth Today
    Via Benzinga
    Analyst Expectations For Insulet's Future
    Via Benzinga
    Here's How Much $1000 Invested In Insulet 15 Years Ago Would Be Worth Today
    Via Benzinga
    (PODD) - Analyzing Insulet's Short Interest
    Via Benzinga
    GE Vernova To Rally Over 30%? Here Are 10 Top Analyst Forecasts For Tuesday
    Via Benzinga
    Upstart, Insulet And 2 Other Stocks Executives Are Selling
    Via Benzinga
    Affirm, Mongodb And Best Buy Are Among Top 10 Large Cap Gainers Last Week (Aug 25-Aug 31): Are The Others In Your Portfolio?
    Via Benzinga
    Why Insulet Stock Was Zooming Higher This Week
    Via The Motley Fool
    Here's How Much You Would Have Made Owning Insulet Stock In The Last 10 Years
    Via Benzinga
    Stocks To Watch Today: PODD, SMCI, And PAYC
    Via Talk Markets
    Exposures Product Safety
    Omnipod® 5 Automated Insulin Delivery System is now FDA-cleared for People with Type 2 Diabetes
    From Insulet Corporation
    Via Business Wire
    S&P 500, Nasdaq 100 Snap 8-Day Winning Streak: What Triggered Wall Street's Setback On Tuesday?
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Insulet to Present at Upcoming Investor Conferences
    From Insulet Corporation
    Via Business Wire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.